Consumer Discretionary • Shoe Manufacturing
$153.13 ▲ +2.61
(+1.73%)
MKT CAP: $6.88B • VOL: 1.50M
52W L $73 52W H $154
CROX // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $4.04B | $4.10B | $3.96B |
| YoY Revenue Growth % | -1.5% | +3.5% | — |
| Gross Profit | $2.36B | $2.41B | — |
| Gross Margin % | 58.3% | 58.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $149.5M | $1.02B | $1.04B |
| Operating Margin % | 3.7% | 24.9% | 26.2% |
| Net Income (GAAP) | -$81.2M | $950.1M | $792.6M |
| EBITDA (Normalized) | $190.5M | $1.08B | $1.18B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $710.4M | $992.5M | $930.4M |
| Capital Expenditures (CapEx) | $51.2M | $69.3M | $178.3M |
| Free Cash Flow (FCF) | $659.2M | $923.1M | $752.1M |
| FCF Margin % | 16.3% | 22.5% | 19.0% |
| Return on Invested Capital (ROIC %) | 4.9% | 26.9% | 28.5% |
| Cash & Short-Term Equivalents | $130.4M | $180.5M | — |
| Total Debt (Short + Long Term) | $1.23B | $1.35B | $1.11B |
| Total Stockholders' Equity | $1.29B | $1.84B | $2.28B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR CROX.